CWAM
AMED

Columbia Wanger Asset Management’s Amedisys AMED Stock Holding History

Columbia Wanger Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$34.8M Buy
659,940
+575,474
+681% +$30.3M 0.52% 82
2017
Q3 		$4.73M Buy
+84,466
New +$4.47M 0.07% 200

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Columbia Wanger Asset Management's AMED Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its Amedisys (AMED) stake by 681% in Q4 2017, buying an estimated $30.3M and bringing the position to 659,940 shares worth $34.8M. The position accounts for 0.52% of the portfolio, ranked #82.

Columbia Wanger Asset Management first reported a position in AMED in Q3 2017 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold AMED as of Q4 2017.

  • Columbia Wanger Asset Management held 659,940 shares of Amedisys worth $34.8M as of Q4 2017.
  • Columbia Wanger Asset Management bought 575,474 Amedisys shares in Q4 2017, an estimated $30.3M.
  • Amedisys made up 0.52% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #82 holding.
  • Columbia Wanger Asset Management first reported a position in Amedisys in Q3 2017 and has held it in 2 quarters since.
  • 188 funds tracked by Wall St. Rank held Amedisys as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.